Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
Science (New York, N.Y.)
|
February 17, 2018
Chromatin regulation and immune escape
Ehsan Ghorani, Sergio A Quezada
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2018
Lost in Translation: Deciphering the Mechanism of Action of Anti-human CTLA-4
Sergio A Quezada, Karl S Peggs
Trends in Immunology
|
June 21, 2015
Fcγ-receptor tag team boosts anti-tumor immunity
Frederick Arce Vargas, Sergio A Quezada
Expert Review of Anticancer Therapy
|
November 27, 2012
PD-1 blockade: promoting endogenous anti-tumor immunity
Karl S Peggs, Sergio A Quezada
Nature Immunology
|
July 22, 2014
An antitumor boost to TH9 cells
Sergio A Quezada, Karl S Peggs
Immunotherapy
|
August 17, 2011
Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities
Sergio A Quezada, Karl S Peggs
Expert Review of Anticancer Therapy
|
November 18, 2010
Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
Karl S Peggs, Sergio A Quezada
Immunity
|
December 22, 2016
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy
James L Reading, Sergio A Quezada
Immunology
|
June 22, 2019
Regulatory T cells in cancer: where are we now?
Awen Gallimore, Sergio A Quezada, Rahul Roychoudhuri
Immunity
|
October 11, 2023
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A Quezada
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
Science (New York, N.Y.)
|
February 17, 2018
Chromatin regulation and immune escape
Ehsan Ghorani, Sergio A Quezada
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2018
Lost in Translation: Deciphering the Mechanism of Action of Anti-human CTLA-4
Sergio A Quezada, Karl S Peggs
Trends in Immunology
|
June 21, 2015
Fcγ-receptor tag team boosts anti-tumor immunity
Frederick Arce Vargas, Sergio A Quezada
Expert Review of Anticancer Therapy
|
November 27, 2012
PD-1 blockade: promoting endogenous anti-tumor immunity
Karl S Peggs, Sergio A Quezada
Nature Immunology
|
July 22, 2014
An antitumor boost to TH9 cells
Sergio A Quezada, Karl S Peggs
Immunotherapy
|
August 17, 2011
Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities
Sergio A Quezada, Karl S Peggs
Expert Review of Anticancer Therapy
|
November 18, 2010
Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
Karl S Peggs, Sergio A Quezada
Immunity
|
December 22, 2016
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy
James L Reading, Sergio A Quezada
Immunology
|
June 22, 2019
Regulatory T cells in cancer: where are we now?
Awen Gallimore, Sergio A Quezada, Rahul Roychoudhuri
Immunity
|
October 11, 2023
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A Quezada
Page
of 13